| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997005862A3 Use of basic amino acids and derivatives for lowering ceramide levels |
| 04/17/1997 | DE19538088A1 Phenanthridinderivate und ihre Herstellung Phenanthridine derivatives and their preparation |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2234511A1 1,3,5-trisubstituted pyrazoles for treatment of inflammation |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
| 04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | EP0767793A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 04/16/1997 | EP0767792A1 Vitronectin receptor antagonists |
| 04/16/1997 | EP0767777A1 New salts of 2- (2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 04/16/1997 | EP0767674A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 04/16/1997 | EP0767661A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 04/16/1997 | EP0672030B1 Process for preparing substantially pure enantiomers of phenylpropionic acids |
| 04/16/1997 | EP0625912B1 Treatment for inflammatory bowel disease |
| 04/16/1997 | CN1147379A Medicinal composite containing 2-(benzylimino)-3-benzyl-1,3-hydrothiazine and its application and prepn |
| 04/16/1997 | CN1147378A Medicinal composite of substituted 1,4,5,6-tetrahydro-diazine-[4,5-c] diazine-5-ketone compounds and its application and prepn |
| 04/16/1997 | CN1034574C Process for preparing (RS)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofuranyl)acetic acids and esters thereof |
| 04/16/1997 | CN1034572C Cyclic anthranilicacid acetic acid derivatives and process for prepn. |
| 04/15/1997 | US5621117 Method for the racemization of enantiomers of α-lipoic acid |
| 04/15/1997 | US5621110 Amidation of an n-carboxyalkyl-2,3-dihydro-3-oxo-1,2-benzisothiazol-2-yl 1,1-dioxide with para-aminophenol |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621098 Process for preparing bis-indolyl macrocycles |
| 04/15/1997 | US5621009 Chondroprotective agents |
| 04/15/1997 | US5621005 Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives |
| 04/15/1997 | US5621000 Nitric esters having a pharmacological activity and process for their preparation |
| 04/15/1997 | US5620999 Antiarthritic, analgesic and antipyratic agent |
| 04/15/1997 | US5620997 Viricides, antiinflammatory agents, antiatherosclerotic agent |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620953 Antiprotozoal cyclic tetrapeptides |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 04/10/1997 | WO1997012963A2 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012892A1 SYNTHETIC MULTIVALENT sLEX CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/10/1997 | WO1997012859A1 Succinimide and maleimide cytokine inhibitors |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012608A1 External antiinflammatory agent |
| 04/10/1997 | WO1997012605A1 Controlled release matrix for pharmaceuticals |
| 04/10/1997 | WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 04/10/1997 | DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs. |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2233300A1 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | CA2231073A1 Synthetic multivalent slex containing polylactosamines and methods for use |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2207084A1 Controlled release matrix for pharmaceuticals |
| 04/10/1997 | CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/09/1997 | EP0767167A1 Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 04/09/1997 | EP0766691A1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
| 04/09/1997 | EP0766676A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/09/1997 | EP0766670A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/09/1997 | EP0766665A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766664A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766565A1 Medical use of bromelain |
| 04/09/1997 | EP0766557A1 Topical compositions comprising n-acetyl-l-cysteine |
| 04/09/1997 | EP0705263B1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 04/09/1997 | EP0345359B1 Novel hydroxamic acid derivative |
| 04/09/1997 | CN1147260A Neurokinine (tachykinine) antagonists |
| 04/09/1997 | CN1147254A Prodrugs of morpholine tachykinin receptor antagonists |
| 04/09/1997 | CN1147201A Halomethyl amides as IL-1 'beta' protease inhibitors |
| 04/09/1997 | CN1034499C Olefine amide compound and its preparing method and use |
| 04/08/1997 | US5618938 Process for preparing stereo isomers of neurokinin receptor antagonists |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618844 Matrix metalloproteinase inhibitor |
| 04/08/1997 | US5618835 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/08/1997 | US5618803 Targeted drug delivery via phosphonate derivatives |
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |
| 04/08/1997 | US5618516 Composition also containing water, thickener, emulsifier, propellant; applied as foam for maximum penetration |
| 04/08/1997 | CA2091360C Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| 04/03/1997 | WO1997011950A1 Metal complexes as cysteine protease inhibitors |
| 04/03/1997 | WO1997011714A1 Chemokine inhibitor |
| 04/03/1997 | WO1997011707A1 Modified ether glyceroglycolipids |
| 04/03/1997 | WO1997011704A1 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents |
| 04/03/1997 | WO1997011693A1 Guanidino protease inhibitors |
| 04/03/1997 | WO1997011684A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | WO1997011668A2 TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS |
| 04/03/1997 | CA2233344A1 Guanidino protease inhibitors |
| 04/03/1997 | CA2233343A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | CA2233168A1 Modified ether glyceroglycolipids |
| 04/03/1997 | CA2232821A1 Metal complexes as cysteine protease inhibitors |
| 04/03/1997 | CA2232706A1 Chemokine inhibitor |
| 04/03/1997 | CA2231764A1 Tumor necrosis factor alpha (tnf-.alpha.) inhibiting pharmaceuticals |
| 04/02/1997 | EP0765884A1 Anti-inflammatory compound |
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765661A2 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765329A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765326A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 04/02/1997 | EP0765305A1 Anti-inflammatory compounds |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765165A1 Constrained peptides |
| 04/02/1997 | EP0739335A4 Pyrrolidine-containing monomers and oligomers |